Table 12:
Scenario Analysis Result, Societal Perspective
| Strategy | Average Total Costs (95% CrI) | Incremental Costa (95% CrI) | Average Total QALYs (95% CrI) | Incremental QALYb (95% CrI) | ICER |
|---|---|---|---|---|---|
| Home NB-UVB | $11,752 (10,171–13,470) | – | 7.38 (7.02–7.74) | – | – |
| Outpatient clinic NB-UVB | $17,023 (13,163–21,196) | $5,271 (1,415–9,354) | 7.10 (6.71–7.47) | −0.29 (−0.81 to 0.24) | Dominated (more costly, less effective) by Home NB-UVB |
Abbreviations: CrI, credible interval; ICER, incremental cost-effectiveness ratio; NB-UVB, narrowband ultraviolet B phototherapy; QALY, quality-adjusted life year.
a
Incremental cost = average cost (strategy B) - average cost (strategy A).
b
Incremental effect = average effect (strategy B) - average effect (strategy A).